文献速递内脏/肾动脉与血管畸形外周动脉疾病

先天性血管畸形患者的大截肢:单中心回顾性分析

Major Limb Amputations in Patients with Congenital Vascular Malformations.
PubMed 文献 · Ann Vasc Surg · 2020-05-18

本研究回顾性分析了2014年4月至2018年11月单中心993例肢体血管畸形患者,其中5例(0.5%)接受大截肢。截肢主要因慢性疼痛和反复出血,术前中位手术11次,无围术期死亡,术后部分患者需再次干预。

要点

  • 肢体血管畸形需大截肢者罕见(0.5%),多因顽固性疼痛、出血或创面不愈。
  • 截肢平面常位于残余畸形处,术前需多学科评估及血管内技术支持。
  • 术后截肢部位溃疡复发需再次干预,血管内技术仍有作用。

核心结论

  • 选择性血管畸形患者可在残余畸形平面成功实施大截肢,以控制顽固性疼痛、出血或创面不愈。

研究设计与样本

  • 单中心回顾性研究,纳入2014年4月至2018年11月共993例上肢或下肢血管畸形患者,分析其中需股骨或肱骨截肢者的临床过程、手术及结局。

主要发现

  • 5例(0.5%)接受大截肢,包括3例肱骨截肢和2例膝上截肢;中位年龄37.8岁(IQR 25.4-40.2),2例(40%)为男性。
  • 4例(80%)为高流量动静脉畸形,其中1例(20%)为Parkes-Weber综合征;1例(20%)为低流量静脉畸形伴Klippel-Trénaunay综合征。
  • 所有患者畸形均延伸至胸部或骨盆,截肢平面位于残余畸形处;术前中位手术11次(IQR 4-39),中位术前治疗时间117个月(IQR 44-171)。
  • 截肢指征包括慢性疼痛和反复出血(5例,100%)、功能丧失(2例,40%)、创面不愈(2例,40%)和脓毒症(1例,20%)。
  • 无围术期死亡;中位失血量1,000 mL(IQR 650-2,750),所有患者均需输注浓缩红细胞,平均1.6单位(SD 0.54);中位住院6天(IQR 5-13)。

临床怎么用

  • 对血管畸形合并顽固性疼痛、出血或创面不愈者,可考虑在残余畸形平面行大截肢,但需多学科评估。
  • 术前及术中可采用经导管栓塞或球囊阻断辅助,术后血管内技术可用于处理截肢部位并发症。

局限性

  • 回顾性单中心设计,样本量小(仅5例截肢),结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The need for major amputations in patients with vascular malformations is rare. This study reviews our contemporary experience with major amputations in patients with vascular malformations. METHODS: A retrospective review from April 2014 to November 2018 identified 993 patients undergoing management of a vascular malformation involving the upper or lower extremity at a tertiary center. This population was analyzed to identify those requiring either a transfemoral or transhumeral amputation. This cohort was investigated for clinical course, surgical procedures, and outcomes. RESULTS: Five patients (0.5%) underwent major amputation, including 3 transhumeral and 2 above-knee amputations. The median age was 37.8 years (interquartile range (IQR): 25.4-40.2), and 2 (40%) were male. Four (80%) patients had high-flow arteriovenous malformations, including 1 (20%) with Parkes-Weber syndrome. One (20%) patient had a low-flow venous malformation associated with Klippel-Trénaunay syndrome. All patients had malformation extending into the chest or pelvis, with the amputation being at the level of residual malformation. As such, amputation had been initially felt to be high risk because of the proximal extent of the lesions. Before amputation, a median of 11 procedures (IQR: 4-39) were performed per patient. This included 29 transarterial embolizations, 4 transvenous embolizations, 20 direct stick embolizations, 3 debulking procedures, 38 debridements, 6 skin grafts or muscle flaps, and 4 minor amputations. The median time course of treatment before amputation was 117 months (IQR: 44-171). Indications for major amputation included chronic pain and recurrent bleeding in all 5 (100%) patients, loss of function in 2 (40%), nonhealing wounds in 2 (40%), and sepsis in 1 (20%) patient. There were no perioperative deaths. The median blood loss was 1,000 mL (IQR: 650-2,750). All patients required transfusion of packed red blood cells with a mean of 1.6 units (standard deviation: 0.54). Transhumeral amputation was facilitated by transcatheter embolization in 1 (33%) and an occlusion balloon within the subclavian artery in 2 (66%) patients. The median length of stay was 6 days (IQR: 5-13). The median length of follow-up was 132 months (IQR: 68-186) from initial intervention and 12 months (IQR: 8-31) from amputation. Two patients (40%) who had undergone transhumeral amputation required revision of the amputation site for recurrent ulceration at 2 and 38 months. Of these, 1 patient underwent 3 transcatheter embolization procedures before revision and 1 underwent 1 embolization after revision. CONCLUSIONS: Although rare, successful amputation at the level of residual malformation can be performed in select patients with refractory complications of vascular malformations including intractable pain, bleeding, or nonhealing wounds. Specific preoperative and intraoperative measures may be critical to achieve satisfactory outcomes, and endovascular techniques continue to play a role after amputation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Conway AM, Qato K, Nguyen Tran NT, et al. Major Limb Amputations in Patients with Congenital Vascular Malformations. Ann Vasc Surg. 2020. PMID: 32439531. doi:10.1016/j.avsg.2020.04.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。